当前位置: 首页 > 保健版 > 家庭健康 > 婴幼儿保健
编号:13754210
匹多莫德辅助治疗婴幼儿反复呼吸道感染疗效观察
http://www.100md.com 2012年4月1日 《中国保健营养·中旬刊》 20124
     【摘 要】目的:研究婴幼儿反复呼吸道感染的治疗方法,探究匹多莫德在婴幼儿反复呼吸道感染的治疗中的作用。方法:以 2010年6月到2011年12月在我院治疗的反复呼吸道感染患儿87例为研究对象,按是否使用匹多莫德辅助治疗分为对照组与观察组,对照组采用常规方法治疗,观察组则在对照组的基础上加用匹多莫德治疗,比较两组患儿的疗效与住院时间。结果:观察组的总有效率(89.6%)明显高于对照组(71.8%),两者差异具统计学意义(P<0.05)。症状改善程度明显优于对照组,观察组平均住院时间(7.5±2.4)天短于对照组的(11.1±3.3)天,两者差异具统计学意义(P<0.05)。结论:匹多莫德在婴幼儿反复呼吸道感染治疗中有显著作用,对再感染率的降低与婴幼儿的健康成长都有着非常重要的帮助,值得我们在临床治疗中进一步推广。

    【关键词】婴幼儿;反复呼吸道感染;匹多莫德

    【中图分类号】R 725.6 【文献标识码】A 【文章编号】1004- 7484(2012)04- 0273- 02

    【abstract】Objective: to study the treatment for recurrent respiratory tract infections, and explore the role of pidotimod in treating the recurrent respiratory tract infections with children. Methods: Take the 87 patients as the research object, who were confirmed with diagnosis of RRTIs and enrolled from June 2010 to December 2011 in our hospital. Those children will be divided into random control group and the observation group, each 50 cases and control with conventional therapy, the observation group is based on routine treatment with pidotimod treatment, compared between the two groups of children’s curative effect and the length of hospitalization. Results: the total effective rate of the observation group was higher than the control group, symptoms improve significantly better than control group, the length of time the shorter than the control group. Conclusion: pidotimod plays a significant role in recurrent respiratory tract infections with children, and also does well both in reducing reinfection rates and helping the growth of children. Further promotion of treatment with pidotimod should be done in the clinical with recurrent respiratory tract infections in children. ......

您现在查看是摘要页,全文长 6577 字符